Jupiros 20 Tablet contains Rosuvastatin 20 mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby decreasing cholesterol production in the liver and promoting increased clearance of LDL particles from the bloodstream. Jupiros 20 is used as an adjunct to diet and lifestyle modifications, including exercise and weight control, to reduce the risk of cardiovascular events such as myocardial infarction, stroke, and the need for revascularization procedures in patients with established coronary artery disease or multiple risk factors. It is also indicated for the treatment of homozygous familial hypercholesterolemia. The dosage should be individualized based on patient response and tolerability, with regular monitoring of lipid levels and liver function tests recommended. Common adverse effects include headache, myalgia, and gastrointestinal disturbances; rare but serious effects include myopathy and hepatotoxicity. Jupiros 20 should be used cautiously in patients with hepatic impairment and contraindicated during pregnancy and lactation.